Since the model is based on an observational cohort study, more details about the cohort would be required. Given the heterogeneity of patients presenting with symptoms suggestive for ACS it would be good to understand how many patients would benefit / be re-classified to high risk / or down-classified, what type of information would be considered in the standard arm. Generally, running a patient-level study might be a more appropriate alternative to address these aspects and estimate the added value of using TDI.
Diagnostic performance variables for TDI were taken from the TEDDY-NSTEACS trial. Still, more information would be required to understand the uncertainty in this parameter. Adding a reference or additional comparative data with the "gold-standard" would be useful.
Several modelling variables are estimated based on the TEDDy-NESTACS trial. Again, it would be helpful to provide more details e.g. in a supplement. In addition to the distribution parameters, ranges used in the PSA should be added to Table 2 to clarify the "95% lower and upper values" (Pg 10/22).
The assumption of reducing LOS by 1 day is derived from two studies both using CT angiography. Goldstein et al. (ref. 25 ) took advantage of a high negative predictive value which helped to rule out low-risk patients more efficiently with a reduction in time to diagnosis of 3.3h (Median). Hoffmann et al. (ref. 26) found a reduction in hospital LOS of 7.6h (Mean) for all patients, and a non-significant increase of 2.7h for ACS patients. As opposed to that, the authors of this study state (pg. 12, line 55) that the value of TDI may be derived from a positive predictive value rather than from ruling-out non-ACS patients. Referring to Hillis et al. (ref. 14) , TDI provides long-term prognostic survival information after acute MI. Against this, it remains unclear how the authors justify the critical input assumptions in this specific setting.
The authors state to follow a health system perspective. Since a reduction in LOS likely translates into cost savings on a hospital level, this is not necessarily and always the case from a health system perspective. Discussing this aspect would be helpful.
It seems obvious that a reduction in LOS (used as input assumption) would translate into hospital cost savings. Testing the uncertainty in the effect plus considering downstream costs (e.g. from follow-up events) would be required to better assess the value of the tested strategy.
Given the uncertainty in input assumptions and the indicative nature of the study, more focus should be spent on sensitivity analyses. Presenting a probabilistic SA graph would be helpful; the tornado diagram does not discuss the most critical variable (Effect size), etc. A more detailed and graphical analysis of the LOS variable would be required (e.g. a threshold analysis using more data points between 0 and 1 day).
Conclusions drawn from the study appear a little premature. Stressing the indicative nature of the study and results not only in the limitations but also in the abstract, and conclusions would be strongly recommended to not misinform the reader.
Others:
• Pg3, Line 8: Spelling mistake: time efficient • The decision tree figure is hard to understand. Please provide more details or a more consistent description of the arms.
• Adding a few more graphics might help the reader to understand
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GENERAL COMMENTS
Well done. It is hard to imagine that there is not long term benefit to early recognition and angiography for high risk NSTEACS patients, but I appreciate the fact that you did not try to prove that point but instead made cost of care the endpoint of your analysis. One thing that you could do to improve the abstract and manuscipt is to state more clearly (in your abstract and methods) that your intervention -TDI at 4-hours -was a hypothetical intervention, and that modeling and assumptions were based on patient data from the TEDDy-NSTEACS study in which the patients had echocardiography within 24 hours of admission. There are many assumptions in your model, as long as it is clearly stated and readers can clearly understand your model. As written the manuscript is a bit confusing and the abstract is somewhat misleading.
VERSION 1 -AUTHOR RESPONSE
Response to Reviewers' Comments:
Reviewer #1
The paper addresses an important aspect of continuously seeking for a more efficient delivery of health care in an environment of limited resources. The study is testing the hypothesis of using Tissue Doppler Imaging for triaging patients in the emergency department presenting with suspected ACS.
The manuscript is technically well written. However, several modelling assumptions would require further clarification and details.
1. Since the model is based on an observational cohort study, more details about the cohort would be required. Given the heterogeneity of patients presenting with symptoms suggestive for ACS it would be good to understand how many patients would benefit / be re-classified to high risk / or downclassified, what type of information would be considered in the standard arm. Generally, running a patient-level study might be a more appropriate alternative to address these aspects and estimate the added value of using TDI.
Thank you for your careful review and kind words. We have provided further details on the cohort characteristics in Table 3 (page 12).
We revised text under 'The TEDDy-NSTEACS study' subsection in page 5. The first 3 revised lines (page 5, last paragraph) now read "The TEDDy-NSTEACS study was a prospective cohort study conducted at the Mater Hospital Brisbane between August 2014 and October 2015. Adults (≥18 years) presenting to the ED with chest pain and admitted to the coronary care unit for further diagnostic, prognostic and acute management of suspected NSTEACS were approached for enrolment in this observational cohort study. Patients enrolled in the study had an echocardiography within 24 hours of admission in addition of standard of care and an E/e' was calculated."
We added the following text in the Results section (page 11, first paragraph) "Descriptive characteristics of the participants are listed in Table 3 . During the study period, 2491 patients with chest pain presented to the Mater Hospital ED. Of those, 260 were admitted to the coronary care unit for further evaluation of potential ACS. There were 167 participants suspected of NSTEACS admitted to CCU, of which 51 met inclusion criteria and enrolled in the study."
We agree that patient-level study would be ideal to capture heterogeneous nature of the patient population presenting with symptoms suggestive of ACS. However, the total sample size of this "proof of concept" study was 51. As a result, we constructed a decision tree model.
2. Diagnostic performance variables for TDI were taken from the TEDDY-NSTEACS trial. Still, more information would be required to understand the uncertainty in this parameter. Adding a reference or additional comparative data with the "gold-standard" would be useful.
We provided 95% confidence intervals for the diagnostic performance of TDI, i.e. sensitivity and specificity for NSTEACS in Table 2 , and added a sentence in the 'Diagnostic strategies' subsection (page 7) which reads "When TDI was used as a diagnostic tool for NSTEMI compared to angiogram as gold standard, the specificity of E/e'>14 to detect NSTEMI was 86% (95% CI: 0.72 -0.95) and sensitivity of 67% (95% CI: 0.30 -0.93 )".
3. Several modelling variables are estimated based on the TEDDy-NESTACS trial. Again, it would be helpful to provide more details e.g. in a supplement.
In addition to the distribution parameters, ranges used in the PSA should be added to Table 2 to clarify the "95% lower and upper values" (Pg 10/22).
We have replaced the SE column in Table 2 with 95% CI values for the parameters used in the economic analysis and provided more details in the results section. In addition, characteristics of study participants are presented in Table 3 .
4. The assumption of reducing LOS by 1 day is derived from two studies both using CT angiography. The observation study found that those patients with E/e'>14 were associated with increased MACE as compared with patients with E/e'≤14 (75% vs 15%, p<0.001). No participants died during the study's follow-up of 90 days. The specificity of E/e'>14 to detect NSTEMI was 86%, positive predictive value (PPV) of 50%, and negative predictive value (NPV) of 92%. In a subset of patients (n=29) who had their NSTEACS confirmed by angiography during their admission to discharge, the specificity for E/e'>14 was 100% (20/20), PPV 100% (4/4), and NPV 74% (20/26). Univariate Cox regression and Log-Rank test of Kaplan-Meier survival curves for E/e' >14 to 90 days, showed that risk for MACE was significantly greater if E/e'>14; hazard ratio [HR]=7.24 (95% CI: 2.56, 20.47). The preliminary outcome data does suggest that E/e'>14 is concerning for adverse outcome and E/e'<14 reassuring for improved outcome.
We agree that Hillis et al. study provided long-term survival information in patients classified according to an E/e' ratio of ≤15 or >15. However, our model includes patients suspected of NSTEACS, follows them up to hospital discharge home. The analysis only compares the cost implications of utilising TDI as a diagnostic tool due to assumed reduced LOS because of early diagnosis.
5. The authors state to follow a health system perspective. Since a reduction in LOS likely translates into cost savings on a hospital level, this is not necessarily and always the case from a health system perspective. Discussing this aspect would be helpful.
We agree that reduction in LoS likely translated into cost savings on a hospital level. In our analysis, the time horizon included was from hospital admission until discharge, i.e. health care costs to discharge are those accrued in the hospital. To reflect this, we have revised the wording and changed to 'health care perspective'.
6. It seems obvious that a reduction in LOS (used as input assumption) would translate into hospital cost savings. Testing the uncertainty in the effect plus considering downstream costs (e.g. from follow-up events) would be required to better assess the value of the tested strategy.
As mentioned in response #5, the time horizon of the analysis was until discharge only and the analysis assumed equivalent outcomes at discharge which we included as study limitation (in page 15, 2nd paragraph). Hence only hospital costs were only relevant costs and did not include downstream costs. We've performed additional probabilistic sensitivity analyses around the reduction in LoS and presented the PSA results in Figure 3. 7. Given the uncertainty in input assumptions and the indicative nature of the study, more focus should be spent on sensitivity analyses. Presenting a probabilistic SA graph would be helpful; the tornado diagram does not discuss the most critical variable (Effect size), etc. A more detailed and graphical analysis of the LOS variable would be required (e.g. a threshold analysis using more data points between 0 and 1 day).
In response to point #6, we have performed extensive SA around the main effect, i.e. assumption on reduction in the LOS in the TDI arm (Figure 3 ).
8. Conclusions drawn from the study appear a little premature. Stressing the indicative nature of the study and results not only in the limitations but also in the abstract, and conclusions would be strongly recommended to not misinform the reader.
Conclusions have been revised. It now reads as "Based on data from a pilot cohort study, this economic analysis indicates that the addition of TDI to the conventional risk stratification approach for triaging adults with suspected NSTEACS in the ED has the potential to save healthcare costs of approximately AU$1,100 per patient between hospital admission to discharge. However, this study makes a number of assumptions and should be considered to be indicative only. Further studies are needed to confirm the clinical effectiveness of TDI in risk stratification for ACS, reduction in hospital stay and long-term outcomes, and the resulting cost-effectiveness."
9. Others:
• Pg3, Line 8: Spelling mistake: time efficient
Thank you for identifying the typo. We corrected this in the revised version.
• The decision tree figure is hard to understand. Please provide more details or a more consistent description of the arms.
We have now provided more consistent and detailed description of the decision tree arms. First two paragraphs in 'model overview' under methods section provide a more detailed description of the arms. We also provide a description of arms in Figure 1 In addition, we have added the following text under model overview (first paragraph, page 10) to make our modelling approach clearer: "Decision tree probabilities were derived by analysing data from the cohort of 51 patients. These are the mean values. Likewise, unit costs of echocardiography, angiography and ED admission were mean costs. The cost of hospital stay (inpatient) was estimated using a weighted average of price weights of 15 DRG codes observed in the cohort study and the costing used the Australian National Weighted Activity Units and AR-DRG prices [27] ."
In response to comments #6 and #7, we have included more graphics showing the impact of the reduction in LOS into cost savings (Figure 3 ).
Reviewer # 2
Well done. It is hard to imagine that there is not long term benefit to early recognition and angiography for high risk NSTEACS patients, but I appreciate the fact that you did not try to prove that point but instead made cost of care the endpoint of your analysis.
One thing that you could do to improve the abstract and manuscipt is to state more clearly (in your abstract and methods) that your intervention -TDI at 4-hours -was a hypothetical intervention, and that modeling and assumptions were based on patient data from the TEDDy-NSTEACS study in which the patients had echocardiography within 24 hours of admission. There are many assumptions in your model, as long as it is clearly stated and readers can clearly understand your model. As written the manuscript is a bit confusing and the abstract is somewhat misleading.
Thank you for the suggestions. We have revised abstract and study methods section to incorporate the suggestion. 
GENERAL COMMENTS
I very much appreciate the efforts the authors undertook to address and clarify comments and questions. Still, I would have two questions of understanding.
